## VRNS: Varonis Systems, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -1.9% below STRENGTH zone (4.0-10.0%); PEG 6.84 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (50% of avg), momentum weakening (-3.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($29.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-30 | Stephens & Co. | $40 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-30 | Stephens & Co. | init | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.7% (+3.6%)
- Blackrock Inc.: 9.0% (-6.9%)
- Voya Investment Mana: 2.8% (-0.4%)
- First Trust Advisors: 2.7% (+7.9%)
- Goldman Sachs Group : 2.5% (-22.0%)

### Key Risks

1. Valuation stretched: PEG 6.8x requires aggressive growth execution.
2. Long-term trend broken: trading 32.3% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 6.84 signals overvaluation risk, limited margin of safety. Forward P/E 95.3x attractive for 164% earnings growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $3.8B |
| Beta | 0.64 |
| 52W Range | $30.02 - $63.90 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.84 |
| Forward P/E | 95.3 |
| Current P/E | 252.0 |
| YoY Growth | 164.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 1.7% to -1.9% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >4.0% for momentum thesis). Below SMA200 (0.68x), long-term trend not supportive. Volume at 50% of 20MA suggests lack of conviction. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.91% (CS: 20) | Neutral |
| RSI_14 | 38.0 | Neutral |
| MACD Histogram | 0.31 | Bullish |
| vs SMA20 | 0.975x | Below |
| vs SMA50 | 0.887x | Below |
| vs SMA200 | 0.677x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $32.04
- **Stop Loss:** $29.72 (7.2% risk)
- **Target:** $34.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 517
- **Position Value:** $16,564.68
- **Portfolio %:** 16.56%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-03 (Est: $0.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.06 | +11.0% |
| 2025Q2 | $0.01 | $0.03 | +273.1% |
| 2025Q1 | $-0.05 | $0.01 | +120.8% |
| 2024Q4 | $0.14 | $0.18 | +27.3% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*